Human Repeated Insult Patch Test
NCT03474874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2019-07-16
Summary
Repeated insult patch test on healthy males and females to determine potential contact irritation or contact allergy in the skin
Conditions
- Dermatitis
- Allergy
- Contact Allergy
Interventions
- DEVICE
-
NeoMatriX Collagen Dressing
Collagen wound dressing
Sponsors & Collaborators
-
NeXtGen Biologics, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-26
- Primary Completion
- 2018-04-06
- Completion
- 2018-04-06
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
NCT00133341 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Experience and Quality of Patch Testing on the Legs vs Back
NCT06191627 ·Status: RECRUITING ·Phase: NA
-
Human Skin Safety Testing of Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT06884215 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
NCT03406117 ·Status: COMPLETED ·Phase: PHASE4
-
Cutaneous and Systemic Reactions to Metal Implants
NCT02483728 ·Status: TERMINATED ·Phase: NA
-
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671 ·Status: RECRUITING ·Phase: NA
-
HRIPT for Collagen Dressing
NCT06283173 ·Status: COMPLETED ·Phase: NA
-
Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT07100912 ·Status: COMPLETED ·Phase: NA
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
18850 - Human Photoallergy Test
NCT02751463 ·Status: COMPLETED ·Phase: NA
-
Metal Panel Allergen Patch Test Study
NCT04500834 ·Status: UNKNOWN ·Phase: PHASE3
-
Allergy Skin Patch Artificial Intelligence (AI)
NCT05339750 ·Status: COMPLETED ·Phase: NA
-
Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly
NCT03309059 ·Status: COMPLETED ·Phase: NA
-
Dermal Cumulative Irritant Patch Study
NCT04064125 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser
NCT01888887 ·Status: COMPLETED ·Phase: NA
-
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion
NCT01892423 ·Status: COMPLETED ·Phase: NA
-
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
NCT07109453 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
NCT05079607 ·Status: COMPLETED ·Phase: NA
-
Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT
NCT04510675 ·Status: COMPLETED ·Phase: NA
-
Human Comedogenicity Test
NCT03428997 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
NCT02615249 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis
NCT00883311 ·Status: COMPLETED ·Phase: PHASE2
-
Neo-Synalar Modified 48 Hour Patch Test
NCT02168478 ·Status: COMPLETED ·Phase: PHASE4
-
Cumulative Irritation Potential of 828 Ointment
NCT00767455 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159 ·Status: COMPLETED ·Phase: NA